Free Trial
→ SpaceX will crumble without these 5 companies (From InvestPub) (Ad)tc pixel
OTCMKTS:DGNOF

DIAGNOS Q1 2026 Earnings Report

DIAGNOS logo
$0.14 0.00 (-1.94%)
As of 11:34 AM Eastern
ProfileEarnings History

DIAGNOS EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

DIAGNOS Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

DIAGNOS Announcement Details

Quarter
Q1 2026
Date
8/20/2025
Time
During Market Hours
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

DIAGNOS' next earnings date is estimated for Monday, August 24, 2026, based on past reporting schedules.

Conference Call Resources

DIAGNOS Earnings Headlines

Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform
June 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/05/3307455/0/en/emerging-growth-research-releases-flash-report-on-diagnos-highlighting-regulatory-catalysts-and-commercialization-potential-for-cara-ai-platform.html
DIAGNOS to Present at the Emerging Growth Conference on June 10, 2026
June 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/03/3306199/0/en/diagnos-to-present-at-the-emerging-growth-conference-on-june-10-2026.html
SpaceX will crumble without these 5 companies
The SpaceX IPO is drawing near, but the real opportunity may lie in 5 lesser-known companies providing the critical infrastructure SpaceX depends on to operate. Goldman Sachs and Morgan Stanley are reportedly already building positions in one of these names. Another is a resource miner that Elon Musk's broader empire - including Tesla - relies on. Lance Ippolito has detailed all five inside his free SpaceX Investing Blackbook.tc pixel
June 15 at 1:00 AM  |  InvestPub (Ad)
DIAGNOS Announces Amendment to Convertible Debentures
May 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/13/3294556/0/en/diagnos-announces-amendment-to-convertible-debentures.html
DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA
April 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/08/3270399/0/en/diagnos-provides-an-update-on-sales-and-regulatory-activities-for-cara.html
DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration
April 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/01/3266834/0/en/DIAGNOS-Successfully-Completes-the-Renewal-of-US-FDA-Medical-Device-Establishment-Registration.html
See More DIAGNOS Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like DIAGNOS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DIAGNOS and other key companies, straight to your email.

About DIAGNOS

DIAGNOS (OTCMKTS:DGNOF) provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

View DIAGNOS Profile
Earnings Tools